Je dividenda Hubei Minkang Pharmaceutical bezpečná?
Hubei Minkang Pharmaceutical zvyšuje dividendu již 0 let.
V průběhu posledních 8 let Hubei Minkang Pharmaceutical tuto hodnotu zvyšovala o 0 % ročně sníženo.
Na pětiletou perspektivu klesl výplata o 0 %.
Analytici počítají pro běžný obchodní rok s růstem o Snížení dividendy ve výši -100,000%.
Hubei Minkang Pharmaceutical Aktienanalyse
Co dělá Hubei Minkang Pharmaceutical?
Hubei Minkang Pharmaceutical Ltd is a Chinese pharmaceutical company that was founded in 1988. Since its establishment, the company has specialized in the development, production, and sale of medicines, particularly traditional Chinese medicines.
The company is based in Xianning City, Hubei Province, and employs over 1,000 staff, including over 400 technicians and researchers. It is a leading manufacturer of medicines in China and has a good reputation in the national and international markets.
Hubei Minkang Pharmaceutical has a wide business model that specializes in the development and marketing of medicines in various areas. These include:
- Traditional Chinese Medicine: Traditional Chinese Medicine (TCM) is one of the company's specialties. TCM is a holistic approach that focuses on the body's natural healing powers. It involves the use of plants, minerals, and animal products to treat diseases and ailments. The company develops and produces a variety of TCM products that are highly valued by Chinese society.
- State-of-the-Art Medicines: The company has also invested in modern medicines in recent years and has a specialized research and development department to develop these products. The portfolio also includes impressive developments in cancer therapy and treatment options for cardiovascular diseases.
- Veterinary Medicine: Hubei Minkang Pharmaceutical Ltd also produces a wide range of products used in veterinary medicine. This includes remedies for parasites, antibiotics, and vitamins.
- Research and Development: The company has established itself as an innovation driver through investment in the research and development of medicines.
Hubei Minkang Pharmaceutical Ltd has been awarded with high-quality assurance and boasts a modern production facility that is standardized at the international level. The company has also received certifications from global institutions such as Good Manufacturing Practice (GMP).
This ensures that all products are of the highest quality, safety, and efficacy. The company is committed to achieving its self-set corporate goals in a sustainable manner, thus creating a sense of shared responsibility towards the environment and society.
Overall, Hubei Minkang Pharmaceutical Ltd is a company that focuses on the development, production, and sale of medicines, particularly traditional Chinese medicine. It has established itself as a successful player in the national and international markets through its specialized divisions and modern manufacturing processes. Hubei Minkang Pharmaceutical je jednou z nejoblíbenějších společností na Eulerpool.com.Akciové spořicí plány nabízí atraktivní možnost pro investory, jak dlouhodobě budovat jmění. Jednou z hlavních výhod je takzvaný průměrovací efekt nákladů: Pravidelnou investicí fixní částky do akcií nebo akciových fondů se automaticky nakupuje více podílů, když jsou ceny nízké, a méně, když jsou vysoké. To může vést k výhodnější průměrné ceně za podíl v průběhu času. Akciové spořicí plány navíc umožňují i malým investorům přístup k drahým akciím, protože se mohou zúčastnit už s malými částkami. Pravidelná investice také podporuje disciplinovanou investiční strategii a pomáhá vyhýbat se emočním rozhodnutím, jako je impulzivní nákup nebo prodej. Kromě toho investoři profitují z potenciálního zhodnocení akcií a z výplat dividend, které mohou být reinvestovány, což zvyšuje efekt složeného úroku a tím růst investovaného kapitálu.